These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17578674)
1. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Brayden DJ; Griffin J Vet Res Commun; 2008 Jan; 32(1):93-106. PubMed ID: 17578674 [TBL] [Abstract][Full Text] [Related]
2. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199 [TBL] [Abstract][Full Text] [Related]
3. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor. Agarwal S; Pal D; Mitra AK Int J Pharm; 2007 Jul; 339(1-2):139-47. PubMed ID: 17451894 [TBL] [Abstract][Full Text] [Related]
4. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice. Geyer J; Gavrilova O; Petzinger E J Vet Pharmacol Ther; 2009 Feb; 32(1):87-96. PubMed ID: 19161460 [TBL] [Abstract][Full Text] [Related]
5. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein. Ji Y; Morris ME Biochem Pharmacol; 2005 Aug; 70(4):640-7. PubMed ID: 16002050 [TBL] [Abstract][Full Text] [Related]
6. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME; Podila L; Ely D; Almeida I Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365 [TBL] [Abstract][Full Text] [Related]
7. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. Tang F; Ouyang H; Yang JZ; Borchardt RT J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695 [TBL] [Abstract][Full Text] [Related]
8. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Nies AT; Herrmann E; Brom M; Keppler D Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of the expression of endogenous Mdr1 P-glycoprotein enhances lipid translocation in MDCK cells transfected with human MRP2. Raggers RJ; Vogels I; van Meer G Histochem Cell Biol; 2002 Feb; 117(2):181-5. PubMed ID: 11935294 [TBL] [Abstract][Full Text] [Related]
10. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport. Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635 [TBL] [Abstract][Full Text] [Related]
11. Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids. Hariharan S; Gunda S; Mishra GP; Pal D; Mitra AK Pharm Res; 2009 May; 26(5):1270-82. PubMed ID: 18958406 [TBL] [Abstract][Full Text] [Related]
12. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753 [TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs. Yu L; Shen Q; Zhou Q; Jiang H; Bi H; Huang M; Zhou H; Zeng S J Ethnopharmacol; 2013 Nov; 150(2):485-91. PubMed ID: 24036064 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates. Ozgür B; Saaby L; Langthaler K; Brodin B Eur J Pharm Sci; 2018 Jan; 112():112-121. PubMed ID: 29146563 [TBL] [Abstract][Full Text] [Related]
15. Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport. Tolle-Sander S; Grill A; Joshi H; Kapil R; Persiani S; Polli JE J Pharm Sci; 2003 Oct; 92(10):1968-80. PubMed ID: 14502537 [TBL] [Abstract][Full Text] [Related]
16. Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines. Dalzell AM; Mistry P; Wright J; Williams FM; Brown CD Toxicol Lett; 2015 Jun; 235(3):189-98. PubMed ID: 25865432 [TBL] [Abstract][Full Text] [Related]
17. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP. Xiao L; Yi T; Chen M; Lam CW; Zhou H Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Luna-Tortós C; Fedrowitz M; Löscher W Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116 [TBL] [Abstract][Full Text] [Related]
19. Establishment of optimized MDCK cell lines for reliable efflux transport studies. Gartzke D; Fricker G J Pharm Sci; 2014 Apr; 103(4):1298-304. PubMed ID: 24532159 [TBL] [Abstract][Full Text] [Related]
20. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Cui Y; König J; Buchholz JK; Spring H; Leier I; Keppler D Mol Pharmacol; 1999 May; 55(5):929-37. PubMed ID: 10220572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]